Keyphrases
Neutropenia
100%
Parvovirus B19
100%
Rituximab Therapy
100%
Rituximab
75%
Monoclonal Antibody
25%
Delayed Onset
25%
Viral Infection
25%
Surface Antigen
25%
Bone Marrow
25%
Severe Neutropenia
25%
B Cells
25%
CD20
25%
Thrombocytopenia
25%
Favorable Prognosis
25%
Absolute Neutrophil Count
25%
Liver Function Tests
25%
Antibody Targeting
25%
Primary Biliary Cirrhosis
25%
Thrombocyte Count
25%
Immune Thrombocytopenic Purpura
25%
Medicine and Dentistry
Neutropenia
100%
Parvovirus B19
100%
Rituximab
100%
Monoclonal Antibody
20%
B Cell
20%
Idiopathic Thrombocytopenic Purpura
20%
Platelet
20%
Thrombocytopenia
20%
Fifth Disease
20%
Virus Infection
20%
Membrane Antigen
20%
Primary Biliary Cirrhosis
20%
CD20 Antigen
20%
Absolute Neutrophil Count
20%
Liver Function Test
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neutropenia
100%
Rituximab
100%
Human Parvovirus B19
100%
Monoclonal Antibody
20%
Idiopathic Thrombocytopenic Purpura
20%
Virus Infection
20%
Membrane Antigen
20%
Thrombocytopenia
20%
CD20 Antigen
20%
Primary Biliary Cirrhosis
20%
Erythema Infectiosum
20%
Immunology and Microbiology
Rituximab
100%
Human Parvovirus B19
100%
Monoclonal Antibody
20%
Membrane Antigen
20%
Neutrophil Count
20%
B Cell
20%
Lineages
20%
Viral Disease
20%
Platelet Count
20%
CD20 Antigen
20%
Liver Function
20%
Idiopathic Thrombocytopenic Purpura
20%
Primary Biliary Cirrhosis
20%